Eric Gornstein is the founder of Talaris Therapeutics. Talaris Therapeutics has raised $100M in total funding. Latest round: Series A. Based in Boston, MA.
Eric Gornstein is null. Talaris Therapeutics, a biotechnology company based in Boston, MA, and Louisville, KY, is developing cell therapies designed to eliminate chronic immunosuppression for organ transplant recipients. The company closed a $100 million Series A financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library